Why the Incitec Pivot Ltd share price could continue its winning streak

Shares in Incitec Pivot Ltd (ASX:IPL) are up over 35% since September.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Wednesday morning, Incitec Pivot Ltd (ASX: IPL) updated the market on the operation of its world-class ammonia plant in Louisiana, United States.

Wednesday's announcement revealed Incitec's plant in Waggaman, Louisiana, is operating at 73% uptime relative to its 800,000 metric tonne per annum capacity. This has enabled Incitec to produce over 140,000 tonnes of ammonia since the plant was transferred to Incitec on 19 October 2016.

Whilst the current uptime is less than the forecast average uptime of 80% over the first 12 months, the announcement reiterated that Incitec remains on track to move to 100% uptime towards the end of this year.

Furthermore, the big positive from Wednesday's update is that Incitec will receive delay damages from the contractor to the tune of US$35.1 million.

These achievements are why I think Incitec is worth a closer look.

Delay damages

Incitec revealed that as part of finalising its contractual arrangements, the construction contractor agreed to pay damages of US$35.1 million for delay in handover of the plant under the lump sum turnkey construction contract.

Incitec will classify the one-off payment as income for the current year, implying that earnings (including individually material items) should be up on 2016 numbers. This is a favourable outcome for management, given the plant was constructed below its US$850 million budget, and speaks volumes of its leadership ability.

Analyst forecasts

Analysts at Macquarie Group Ltd (ASX: MQG) share my sentiment, revealing in a December research note that Incitec is well positioned to outperform the market.

The investment bank revealed that higher oil prices should support fertiliser prices moving forward, benefitting low cost producers like Incitec. Accordingly, Macquarie analysts remain positive on the stock, slapping a $3.88 12-month price target on the shares as a result of the increased output the Waggaman plant should provide and management's proven ability to control costs.

Similarly, Deutsche Bank rates Incitec a buy with a 12-month price target of $3.95 a share. The German investment bank cites industry consolidation as a key driver for further price gains, given marginal cost producers are expected to decrease. Deutsche Bank therefore contends that the ammonia market should tighten, benefitting high quality producers like Incitec and Orica Ltd (ASX: ORI).

Should you buy?

Whilst analysts' ratings should not be solely relied upon as a basis for investment, the telling trait that makes Incitec a solid stock to own is its management's ability to deliver.

Although Wednesday's announcement indicates that the plant is running below forecast uptime levels, management reiterated that its previous target of 80% average uptime should be achieved by year end.

Moreover, the successful negotiations for delay damages represents a favourable outcome for shareholders, adding to management's prior achievement of delivering a facility that is in the top 2% of projects globally.

Foolish takeaway

In my view, Incitec's pullback following Wednesday's announcement appears to be unwarranted and may be driven by the broader S&P/ASX 200 Index (ASX: XJO) sell-off.

Given Incitec's management has a proven track record of delivering on time, and within budget, I'd expect any hiccups to be short-lived.

As such, I believe investors should take the pullback as an opportunity to buy Incitec shares given the broader industry themes at play.

Motley Fool contributor Rachit Dudhwala has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »